Elena Bartoloni

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

Raphaèle Séror, Hendrika Bootsma, Alain Saraux et al. · Annals of the Rheumatic Diseases · 2014 · 295 citations

Primary Sjögren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients

Chiara Baldini, Pasquale Pepe, Luca Quartuccio et al. · Lara D. Veeken · 2013 · 260 citations · Full text

Validation of EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)

Raphaèle Séror, Elke Theander, Johan G. Brun et al. · Annals of the Rheumatic Diseases · 2014 · 259 citations

CD4+CD28− T Lymphocytes Contribute to Early Atherosclerotic Damage in Rheumatoid Arthritis Patients

Roberto Gerli, Giuseppe Schillaci, Andrea Giordano et al. · Circulation · 2004 · 248 citations

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

Lorenzo Cavagna, Ernesto Trallero‐Araguás, Federica Meloni et al. · Journal of Clinical Medicine · 2019 · 200 citations · Full text

Asthma, Rheumatology, Antisynthetase Syndrome +14